Font size
- 1 2 3 + Font size

click to adjust

Page tools
Search
. Advanced search

A Targeted Approach to HealthCare

Bayer HealthCare Pharmaceuticals' goal is to discover products that will improve human health worldwide by diagnosing, preventing and treating diseases. As a specialty pharmaceutical company, we focus our efforts where we can have the most impact.

For more than 100 years, Bayer has been dedicated to developing, manufacturing and marketing pharmaceuticals. Built on the company's long history of providing medicines that healthcare providers and patients can trust, Bayer is one of the most recognized brands in health care.


Bayer News Releases


24 September 2014
ESMO 2014 to Feature New Oncology Data from Across Bayer Franchise

17 September 2014
Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C

16 September 2014
Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer

08 September 2014
Bayer HealthCare Launches Make Your Mark to Inspire Women and Celebrate Their Achievements

13 August 2014
Over 1,000 Medical Sites in the United States Now Licensed to Administer Xofigo® (radium Ra 223 dichloride) Injection

25 July 2014
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer

 

Press Release Archive

 

Further Information


Clinical Trials

Information about clinical studies is available at clinicaltrials.gov.


http://pharma.bayer.com/scripts/pages/en/index.php/

Copyright © Bayer Healthcare Pharmaceuticals